IV Ceftriaxone

DRUG4 trials

Sponsors

University of Padova, Baxter Healthcare Corporation, Forest Laboratories, RESnTEC, Institute of Research

Conditions

Bacterial PneumoniaCommunity-acquired PneumoniaHealthyUrinary Tract Infections

Phase 1

Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone Administration

CompletedNCT00493220

Baxter Healthcare CorporationHealthy

Start: 2007-06-30End: 2007-09-30Updated: 2011-12-02

Phase 3

Oral vs Initial Intravenous Antibiotic Treatment of Urinary Tract Infections in Children: a RCT

TerminatedNCT00161330

University of PadovaUrinary Tract Infections

Start: 2000-06-30End: 2005-07-31Target: 440Updated: 2020-12-14

Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia

CompletedNCT00621504

Forest LaboratoriesBacterial Pneumonia

Start: 2008-01-31End: 2009-06-30Updated: 2017-03-14

Unknown Phase

Comparison of Efficacy of Oral Amoxicillin Versus Intravenous Ceftriaxone

Not yet recruitingNCT06532409

RESnTEC, Institute of ResearchCommunity-acquired Pneumonia

Start: 2024-10-01End: 2025-09-30Target: 114Updated: 2024-08-01

Related Papers

Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials.

2021-12-162 citations

Assessment of Time to Clinical Response, a Proxy for Discharge Readiness, among Hospitalized Patients with Community-Acquired Pneumonia Who Received either Ceftaroline Fosamil or Ceftriaxone in Two Phase III FOCUS Trials

UNC Libraries2020-10-31

Summary of the safety and tolerability of two treatment regimens of ceftaroline fosamil: 600 mg every 8 h versus 600 mg every 12 h.

2019-04-0111 citations

Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials.

2015-12-2420 citations

Assessment of Time to Clinical Response, a Proxy for Discharge Readiness, among Hospitalized Patients with Community-Acquired Pneumonia Who Received either Ceftaroline Fosamil or Ceftriaxone in Two Phase III FOCUS Trials

Antimicrobial Agents and Chemotherapy2014-12-0923 citations

FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.

2011-04-01117 citations

Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia.

2011-04-0132 citations

Antibiotic treatment for pyelonephritis in children: multicentre randomised controlled non-inferiority trial.

2007-07-04110 citations